Skip to main content

Viemed Healthcare, Inc.

corporate_fare Company Profile

Viemed Healthcare, Inc.

VMD·NASDAQ·Industrial Applications And Services·CIK 0001729149

Viemed Healthcare, Inc. provides home medical equipment (HME) and post-acute healthcare services across the United States, specializing in respiratory, chronic care, and women's health products and services. The company focuses on delivering in-home treatment, with clinical practitioners providing therapy and counseling to patients using technology. Viemed aims to grow by increasing the number of patients served and the level of care provided through its technology-enabled, home-based clinical care and chronic disease management model. Its care programs are designed to treat patients at home for less total cost and with superior quality of care. Viemed's services include respiratory disease management, which involves renting various HME devices, neuromuscular care, in-home sleep testing and sleep apnea treatment, oxygen therapy, and the sale of associated supplies. The company also offers women's health products and services, and healthcare staffing services. Viemed serves patients in all 50 states of the United States. As of December 31, 2025, the company employed 401 licensed respiratory therapists (RTs), who represented approximately 29% of its total employee count. Beyond its internal needs, Viemed also provides healthcare staffing and recruitment services to external healthcare institutions. The company seeks to expand its existing service areas and enter new territories by focusing overhead costs on personnel rather than physical location costs.

Viemed Healthcare, Inc. (NASDAQ:VMD) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 22 items for VMD at importance 7 or higher on its 1–10 market-impact scale.

Recent high-impact activity:

  • CEO Hoyt Casey Increases Direct Ownership Following Equity Award Vesting
  • COO Increases Direct Holdings by 114K Shares via Option Exercise

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$270.28M
Net Income
$14.93M
Diluted EPS
$0.37
Op. Cash Flow
$51.92M
Free Cash Flow
$11.93M
Gross Profit
$155.46M
Operating Income
$22.95M
Cash & Equivalents
$13.5M
Total Debt
$12.38M
Debt / Equity
0.09×
Net Margin
5.5%
Shares Outstanding
38.02M sh
Source: 10-K · filed 2026-03-04 · accession 0001729149-26-000009
$8.59 +0.82% today
52-week range · as of 2026-11-04 $6.05 – $12.61
Market cap
$322.85M
Volume
258.9K (1.2× avg)
3-mo avg 208K
Live data · 2026-11-22 12:47 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed VMD - Filings & News (Page 2)

VMD
Jan 23, 2026, 4:55 PM EST
Filing Type: 4
Importance Score:
7
Price at Filing: $7.32
Real-time Price: $8.59 info
Change: +$1.27 (+17%) info
Market Cap: $322.849M info
VMD
Jan 23, 2026, 4:55 PM EST
Filing Type: 4
Importance Score:
7
Price at Filing: $7.32
Real-time Price: $8.59 info
Change: +$1.27 (+17%) info
Market Cap: $322.849M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets